Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 4 | EJNMMI Radiopharmacy and Chemistry

Fig. 4

From: Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model

Fig. 4

Integration diagram of analytical radio-TLC and radio-HPLC radioactive traces of [89Zr]Zr-DFO-NY003 (A, B) and [177Lu]Lu-DTPA-NY003 (C, D). The developer for TLC was citric acid/ sodium citrate buffer (0.5 M, pH 5). The mobile phase for HPLC was 0.1 M PBS + 0.5 M NaCl solution (E). In vitro stability of [89Zr]Zr-DFO-NY003 and [177Lu]Lu-DTPA-NY003 in saline

Back to article page